Tweet
Scientists from Tomsk Polytechnic University together with their colleagues from St. Petersburg and London have elaborated a new approach to deliver anti-viral RNAi to target cells against H1N1 influenza virus infection. Drug encapsulating via a combination of layer-by-layer technique and sol-gel chemistry allows beating swine flu at the gene level. The first test showed an 80% drop in virus protein synthesis.
A research was conducted by scientists from the Novel Dosage Laboratory, RASA Center at TPU, Pavlov First Saint Petersburg State Medical University, Research Institute of Influenza of Ministry of Healthcare of the Russian Federation and Queen Mary University of London School of Engineering and Materials Science. Scientists from Gorbacheva Research Institute of Pediatric Hematology and Transplantation also took an active part in the research.
A new method to fight influenza A (H1N1) virus is focused on training our body to produce interferons (proteins that make our body immune to the virus) faster.
A research was conducted by scientists from the Novel Dosage Laboratory, RASA Center at TPU, Pavlov First Saint Petersburg State Medical University, Research Institute of Influenza of Ministry of Healthcare of the Russian Federation and Queen Mary University of London School of Engineering and Materials Science. Scientists from Gorbacheva Research Institute of Pediatric Hematology and Transplantation also took an active part in the research.
A new method to fight influenza A (H1N1) virus is focused on training our body to produce interferons (proteins that make our body immune to the virus) faster.
Comment